Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 |
| Research and development | 31.6 | 20.5 | 10.2 | 7.2 |
| General and administrative | 12.6 | 7.0 | 2.1 | 2.1 |
| EBIT | -44.2 | -27.5 | -12.2 | -9.3 |
| Pre-tax income | -37.3 | -29.6 | -12.2 | -13.6 |
| Income taxes | -0.4 | 0.0 | 0.0 | 0.0 |
| Tax rate | 1.2% | | 0.0% | 0.0% |
| Net income | -36.9 | -29.7 | -12.2 | -13.6 |
| |
| Diluted EPS | ($1.26) | ($1.63) | ($1.36) | ($2.46) |
| Shares outstanding (diluted) | 29.2 | 18.2 | 9.0 | 5.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|